MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancerMichael J. G. Milevskiy(The University of Melbourne), Melissa A. Brown(Wellcome Centre for Cell-Matrix Research)British Journal of CancerFebruary 19, 201910.1038/s41416-019-0395-8Cited by 39SaveCiteExport RISWatch citationsRelated PapersRandomized, Double-blind Comparison of Hirulog Versus Heparin in Patients Receiving Streptokinase and Aspirin for Acute Myocardial Infarction (HERO)|Circulation|1997|232Three-dimensional genome architecture coordinates key regulators of lineage specification in mammary epithelial cells|Cell Genomics|2023|11